Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A miRNA signature for defining aggressive phenotype and prognosis in gliomas.

PloS one - 1 Jan 2014

Barbano Raffaela, Palumbo Orazio, Pasculli Barbara, Galasso Marco, Volinia Stefano, D'Angelo Vincenzo, Icolaro Nadia, Coco Michelina, Dimitri Lucia, Graziano Paolo, Copetti Massimiliano, Valori Vanna Maria, Maiello Evaristo, Carella Massimo, Fazio Vito Michele, Parrella Paola

Abstract excerpt

Gliomas represent a disparate group of tumours for which there are to date no cure. Thus, there is a recognized need for new diagnostic and therapeutic approaches based on increased understanding of their molecular nature. We performed the comparison of the microRNA (miRNA) profile of 8 WHO grade II gliomas and 24 higher grade tumours (2 WHO grade III and 22 glioblastomas) by using the Affymetrix GeneChip miRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Glioma

Share to MicroRNAs

Share to Neoplasm Invasiveness

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 25279461
DOI: 10.1371/journal.pone.0108950
PMCID: PMC4184816

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A miRNA signature for defining aggressive phenotype and prognosis in gliomas.PMID 25279461Read ↗

The Clinical Role of miRNAs in the Development and Treatment of GlioblastomaSemantic proximity Read ↗

miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomasSemantic proximity Read ↗

Long non-coding RNA expression profiles predict clinical phenotypes in glioma.Semantic proximity Read ↗

miRNA Multiplayers in glioma. From bench to bedside.Semantic proximity Read ↗

Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapySemantic proximity Read ↗

Prediction of clinical outcome in glioblastoma using a biologically relevant nine‐microRNA signatureSemantic proximity Read ↗

miR-21 as a Diagnostic and Prognostic Biomarker in Glioma: Tissue and Serum Expression Analysis in a Pakistani CohortSemantic proximity Read ↗

Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patientsSemantic proximity Read ↗

A 4-miRNA signature to predict survival in glioblastomasSemantic proximity Read ↗

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and SerumSemantic proximity Read ↗

Colombian Glioblastoma Patients Exhibit Age- and Proliferation- Associated miRNA Signatures Involving the miR-17-92 ClusterSemantic proximity Read ↗

Role of MicroRNAs in Malignant GliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.